BioAtla, Inc.
BCABOTCCIK 1826892HealthcareFiscal year ends Dec 31
Reports and events: 109 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-2416:02 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0000950170-24-047562 |
| 2024-04-1609:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001213900-24-033175 |
| 2024-03-2617:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-036548 |
| 2024-03-2616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-036395 |
| 2024-02-2116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-017881 |
| 2024-02-1216:01 ET | 8-K | 8.01 Other events | 0000950170-24-013807 |
| 2024-01-0909:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-004912 |
| 2024-01-0817:11 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-004539 |
| 2023-12-1308:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-293959 |
| 2023-12-0409:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-288019 |
| 2023-11-0717:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060389 |
| 2023-11-0716:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060210 |
| 2023-08-0117:00 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-036554 |
| 2023-08-0116:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-036440 |
| 2023-06-1417:01 ET | 8-K | 5.07 Shareholder vote results | 0000950170-23-028007 |
| 2023-05-1117:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021358 |
| 2023-05-1116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-021212 |
| 2023-04-2417:12 ET | DEF 14A | Proxy statementPeriod 2023-06-14 | 0000950170-23-014136 |
| 2023-03-2317:06 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-009551 |
| 2023-03-2316:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-009469 |
| 2023-03-1014:32 ET | 8-K | 7.01 Regulation FD disclosure | 0000950170-23-007213 |
| 2023-02-2708:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-049760 |
| 2023-02-1516:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-23-002910 |
| 2023-01-0917:00 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-004819 |
| 2023-01-0616:14 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-003550 |
| 2022-11-0717:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-279214 |
| 2022-11-0406:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-277328 |
| 2022-11-0406:05 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-022036 |
| 2022-11-0316:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-021833 |
| 2022-09-2109:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-22-018700 |
| 2022-08-0917:02 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-016149 |
| 2022-08-0916:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-016024 |
| 2022-06-1709:01 ET | 8-K | 5.07 Shareholder vote results | 0000950170-22-011774 |
| 2022-06-0616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-168316 |
| 2022-05-0516:31 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007871 |
| 2022-05-0416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-007371 |
| 2022-04-2516:12 ET | DEF 14A | Proxy statementPeriod 2022-06-16 | 0001193125-22-117564 |
| 2022-04-1116:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-101666 |
| 2022-02-2816:25 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-002303 |
| 2022-02-2516:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-054400 |
| 2022-01-1117:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000950170-22-000220 |
| 2021-12-2109:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-363150 |
| 2021-11-1916:15 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-21-335170 |
| 2021-11-1516:32 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004617 |
| 2021-10-2216:16 ET | S-1 | Registration statement | 0001193125-21-305435 |
| 2021-09-2908:27 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-21-001919 |
| 2021-09-0317:16 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-265644 |
| 2021-08-1316:33 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-001443 |
| 2021-06-2816:32 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-21-202057 |
| 2021-06-1721:01 ET | 8-K | 5.07 Shareholder vote results | 0000950170-21-000359 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 06:15 ET. Listed shows no prices and gives no investment advice.